Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
View Patent ↗Immunoassays, assay methods, antibodies and methods of producing antibodies for the detection of fibroblast growth factor-23 (FGF-23). The immunoassay and assay method preferably comprise a non-competitive, sandwich-type assay utilizing a first bound antibody having affinity to a first site of the FGF-23 molecule, and a second, labeled antibody having an affinity for a second site present upon the FGF-23 molecule. The antibodies and methods of generating the same include administering antigenic peptide fragments of the FGF-23 molecule, monitoring the antibody titre produced thereby, extracting and selecting antibodies from the antisera having a specificity for the desired antigenic region of FGF-23, and purifying same. The antibodies may be incorporated into the immunoassay of the present invention or utilized for a variety of assay-type purposes for the detection of FGF-23.
1. A non-competitive immunoassay for detecting an FGF-23 protein molecule in a liquid sample suspected of containing molecules of FGF-23, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said immtmoassay comprising the steps of:
(1) contacting said liquid sample with
(a) a first capture antibody, said first antibody having a specificity for a first amino acid sequence present upon the FGF-23 protein molecules wherein the first amino acid sequence includes at least one glycosylated amino acid residue therein,
(b) a second antibody, said second antibody having a specificity for a second amino acid sequence present upon the FGF-23 protein molecule; wherein said specificity of said first antibody is dissimilar to said specificity of said second antibody such that in use, said first and second antibodies are capable of sequentially or simultaneously binding to an FGF-23 molecule; and
(2) detecting complexes of said FGF-23 molecule bound to said first antibody and bound to said second antibody.
2. A non-competitive immunoassay for detecting an FGF-23 protein molecule in a liquid sample suspected of containing molecules of FGF-23, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said immunoassay comprising the steps of:
(1) contacting said liquid sample with
(a) a first-capture antibody, said first antibody having a specificity for a first amino acid sequence present upon the FGF-23 protein molecule;
(b) a second antibody, said second antibody having a specificity for a second amino acid sequence present upon the FGF-23 protein molecules wherein the second amino acid sequence includes at least one glycosylated amino acid residue therein; wherein said specificity of said first antibody is dissimilar to said specificity of said second antibody such that in use, said first and second antibodies are capable of sequentially or simultaneously binding to an FGF-23 molecule; and
(2) detecting complexes of said FGF-23 molecule bound to said first antibody and bound to said second antibody.
3. A non-competitive immunoassay for detecting an FGF-23 protein molecule in a liquid sample suspected of containing molecules of FGF-23, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said immunoassay comprising the steps of:
(1) contacting said liquid sample with
(a) a first capture antibody, said first antibody having a specificity for a first amino acid sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 25, SEQ ID NO. 26, SEQ ID NO. 27, SEQ ID NO. 28, SEQ ID NO. 29, SEQ ID NO. 30, and SEQ ID NO. 31, wherein SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, and SEQ ID NO. 7 have at least one glycosylated amino acid residue therein;
(b) a second antibody, said second antibody having a specificity for a second amino acid sequence present upon the FGF-23 protein molecule; wherein said specificity of said first antibody is dissimilar to said specificity of said second antibody such that in use, said first and second antibodies are capable of sequentially or simultaneously binding to an FGF-23 molecule; and
(2) detecting complexes of said FGF-23 molecule bound to said first antibody and bound to said second antibody.
4. A non-competitive immunoassay for detecting an FGF-23 protein molecule in a liquid sample suspected of containing molecules of FGF-23, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said immunoassay comprising the steps of:
(1) contacting said liquid sample with
(a) a first capture antibody, said first antibody having a specificity for a first amino acid sequence present upon the FGF-23 protein molecules
(b) a second antibody, said second antibody having a specificity for an amino acid sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 25, SEQ ID NO. 26, SEQ ID NO. 27, SEQ ID NO. 28, SEQ ID NO. 29, SEQ ID NO. 30, and SEQ ID NO. 31, wherein SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, and SEQ ID NO. 7 have at least one glycosylated amino acid residue therein; wherein said specificity of said first antibody is dissimilar to said specificity of said second antibody such that in use, said first and second antibodies are capable of sequentially or simultaneously binding to an FGF-23 molecule; and
(2) detecting complexes of said FGF-23 molecule bound to said first antibody and bound to said second antibody.
5. A method of detecting the presence of FGF-23 protein molecules in a liquid sample, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said method comprising the steps:
(a) providing a capture first antibody, said first antibody having a specificity for a first antigenic amino acid sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 25, SEQ ID NO. 26, SEQ ID NO. 27, SEQ ID NO. 28, SEQ ID NO. 29, SEQ ID NO. 30, and SEQ ID NO. 31, wherein SEQ ID Nos. 3 through 7 incorporate at least one glycosylated amino acid residue therein;
(b) contacting said liquid sample with said first antibody such that said FGF-23 molecules become bound thereto;
(c) providing a second antibody having a specificity for a second antigenic amino acid sequence formed upon the FGF-23 molecule, said second amino acid sequence being dissimilar from the sequence for which said first antibody in step a) is specific, said second antibody having a detectable moiety attached thereto; and
(d) contacting said second antibody with said first antibody having said molecules of FGF-23 bound thereto such that said second antibody binds with said FGF-23 molecule; and
(e) detecting the presence of FGF-23 via the detectable moiety attached to said second antibody.
6. A method of detecting the presence of FGF-23 protein molecules in a liquid sample, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said method comprising the steps:
(a) providing a capture first antibody, said first antibody having a specificity for a first amino acid sequence formed upon the FGF-23 molecule;
(b) contacting said liquid sample with said first antibody such that said FGF-23 molecules become bound thereto;
(c) providing a second antibody having a specificity for a second amino acid sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 25, SEQ ID NO. 26, SEQ ID NO. 27, SEQ ID NO. 28, SEQ ID NO. 29, SEQ ID NO. 30, and SEQ ID NO. 31 wherein SEQ ID Nos. 3 through 7 incorporate at least one glycosylated amino acid residue therein, said second amino acid sequence being dissimilar from the sequence for which said first antibody in step a) is specific, said second antibody having a detectable moiety attached thereto; and
(d) contacting said second antibody with said first antibody having said molecules of FGF-23 bound thereto such that said second antibody binds with said FGF-23 molecule; and
(e) detecting the presence of FGF-23 via the detectable moiety attached to said second antibody.
7. A non-competitive immunoassay for detecting an FGF-23 protein molecule in a liquid sample suspected of containing-molecules of FGF-23, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said immunoassay comprising the steps of:
(1) contacting said liquid sample with
(a) a first capture antibody, said first antibody having a specificity for amino acid sequence SEQ ID NO. 24;
(b) a second antibody, said second antibody having a specificity for an amino acid sequence selected from the group consisting of SEQ ID NO. 9 and SEQ ID NO. 4; wherein said first and second antibodies are capable of sequentially or simultaneously binding to an FGF-23 molecule; and
(2) detecting complexes of said FGF-23 molecule bound to said first antibody and bound to said second antibody.
8. A non-competitive immunoassay for detecting an FGF-23 protein molecule in a liquid sample suspected of containing molecules of FGF-23, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said immunoassay comprising the steps of:
(1) contacting said liquid sample with
(a) a first capture antibody, said first antibody having: a specificity for amino acid sequence SEQ ID NO. 28;
(b) a second antibody, said second antibody having a specificity for amino acid sequence SEQ ID NO. 24; wherein said first and second-antibodies are capable of sequentially or simultaneously binding to a molecule FGF-23; and
(2) detecting complexes of said FGF-23 molecule bound to said first antibody and bound to said second antibody.
9. A method of detecting the presence of FGF-23 protein molecules in a liquid sample, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said method comprising the steps:
(a) providing a capture first antibody, said first antibody having a specificity for a first antigenic amino acid sequence SEQ ID NO. 24;
(b) contacting said liquid sample with said first antibody such that said FGF-23 molecules become bound thereto;
(c) providing a second antibody having a specificity for a second antigenic amino acid sequence selected from the group consisting of SEQ ID NO. 4 and SEQ ID NO. 9, said second antibody having a detectable moiety attached thereto; and
(d) contacting said second antibody with said first antibody having said molecules of FGF-23 bound thereto such that said second antibody binds with said FGF-23 molecule; and
(e) detecting the presence of FGF-23 via the detectable moiety attached to said second antibody.
10. A method of detecting the presence of FGF-23 protein molecules in a liquid sample, wherein the FGF-23 protein molecule has an amino acid sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2, said method comprising the steps:
(a) providing a capture first antibody, said first antibody having a specificity for a first amino acid sequence SEQ ID NO. 28;
(b) contacting said liquid sample with said first antibody such that said FGF-23 molecules become bound thereto;
(c) providing a second antibody having a specificity for a second amino acid sequence SEQ ID NO. 24, said second antibody having a detectable moiety attached thereto; and
(d) contacting said second antibody with said first antibody having said molecules of FGF-23 bound thereto such that said second antibody binds with said FGF-23 molecule; and
(e) detecting the presence of FGF-23 via the detectable moiety attached to said second antibody.